Beijing Biostar Pharmaceuticals Co., Ltd. announced a revised list of directors and committee assignments, effective 26 June 2026.

Board leadership • Dr. Tang Li assumes the dual role of Board Chairperson while continuing as Chief Scientific Officer and Chief Marketing Officer. • Dr. Qiu Rongguo serves as Vice-chairperson, Chief Executive Officer and General Manager. • Executive directorship is further supported by Mr. Zhang Cheng and Dr. Guan Jin, both Deputy General Managers. • Non-executive directors are Mr. Tang Jin and Ms. Dai Xuefen. • Independent non-executive directors (INEDs) include Mr. Manfred Shiu Shu Ming, Dr. Ye Chengang and Dr. Zhu Xiaodong.

Committee composition • Audit Committee: chaired by INED Mr. Manfred Shiu Shu Ming; members include Dr. Qiu Rongguo and Mr. Tang Jin. • Nomination Committee: chaired by INED Dr. Ye Chengang; members comprise Dr. Tang Li and Ms. Dai Xuefen. • Remuneration and Appraisal Committee: chaired by INED Dr. Zhu Xiaodong; committee members are Mr. Manfred Shiu Shu Ming and Dr. Ye Chengang. • Strategy Committee: chaired by Dr. Tang Li with Dr. Qiu Rongguo and Dr. Zhu Xiaodong as members.

The updated structure highlights a balanced mix of executive, non-executive and independent directors, with INEDs holding key oversight roles across the Audit, Nomination, and Remuneration committees.